The following is the latest news from GSID. For a complete list of publications authored by GSID researchers, please click here.
December 11, 2012
GSID continues to collaborate with our research partners around the world to expand our understanding of HIV. GSID has contributed to further analysis of the RV144 trial with recent papers in the Journal of Virology, AIDS Research and Human Retroviruses, and the Journal of Infectious Diseases. Dr. Faruk Sinangil, our Managing Director of Research & Development, also contributed to another Journal of Virology paper on a swarm analysis of HIV virus variation both within individuals and between them. In addition, Executive Director Don Francis recently took a look back on 30 years of US government AIDS policy, in a commentary piece for the Journal of Public Health Policy. For a complete list of publications by GSID researchers, please see here.
July 6, 2012
In the July 6, 2012 issue of Vaccine, Don Francis and his co-authors provide a detailed estimate of the cost of production of a live attenuated dengue vaccine, using Instito Butantan as a case study. A complete list of all publications from GSID researchers can be found here.
June 14, 2012
GSID continues to work with HIV vaccine researchers around the world to analyze the results of the Thai HIV vaccine trials. This month, GSID researchers co-authored a new analysis of neutralizing antibody responses to HIV in two vaccine trials in Thailand (RV144 and VAX003), which was published in the
Journal of Infectious Diseases. A complete list of all publications from GSID researchers can be found
here.
June 1, 2012
Don Francis calls for greater independence for the CDC in a Viewpoint published in the most recent issues of
AIDS, the official journal of the International AIDS Society. A complete list of all publications from GSID researchers can be found
here.
September 12-14, 2011
The results of the correlates of protection studies from the RV144 trial were presented at the AIDS Vaccine 2011 conference in Bangkok Thailand. A brief discussion of the results can be found here. The results of the follow-on trial, RV152, are also discussed here. Several of GSID's collaborators also presented a number of posters at the. For more information, please see our list of publications.
September 8, 2011
The results of the RV152 study were presented at the AIDS Vaccine 2011 conference in Bangkok Thailand. A brief discussion of the results can be found here. Several of GSID's collaborators also presented a number of posters at the. For more information, please see our list of publications.
July 17, 2011
GSID was selected as one of the 77 finalist innovators for Saving Lives at Birth: A Grand Challenge for Development. A description of our proposal to develop an Antenatal Disease Diagnosis and Reporting Instrument can be found here.
December 1, 2010
Dr. Don Francis has published an Occasional Paper for the Pediatric Dengue Vaccine Initiative on The Manufacture and Supply of Dengue Vaccine. A copy of the paper is available here.
September 1, 2010
Dr. Don Francis examines the historic successes and failures of vaccines worldwide, as well as looking with great optimism towards developing new vaccines in a new article published in the September 2010 issue of Biologicals. A copy of “Successes and Failures: Worldwide vaccine development and application” is available here.
December 8, 2009
GSID is pleased to announce that the results of the Thai Phase III HIV Vaccine trial have earned GSID and our partners TIME’s Number 2 Medical Breakthrough of the Year and Number 8 of the Time’s Top 50 Best Inventions of 2009.
December 3, 2009
Speaking at the Fourth Annual CAVD meeting in Miami, Dr. Faruk Sinangil provided an update on GSID and consortium members’ work for our program “A Path to an HIV Vaccine.” A copy of his presentation is available here.
October 20, 2009
Detailed results from the Thai Phase III HIV vaccine clinical trial were presented at the AIDS Vaccine 2009 Conference in Paris, France, and published online in The New England Journal of Medicine. In Paris, Dr. Supachai of the Thailand Ministry of Public Health presented the RV144 trial results, and Col. Michael of the US Military HIV Research Program presented primary and subgroup analysis of the trial. A webcast of the Thai Trial Special Session is available on the AIDS Conference 2009 website. The article published in the New England Journal of Medicine and co-authored by Dr. Donald Francis is available here. A press release and related FAQ from the MHRP are available here.
October 11, 2009
Dr. Faruk Sinangil has co-authored a paper for Molecular Biology and Evolution, which looks at the phylodynamics of HIV-1 in the VAX004 trial in North America. The paper is available here.
September 24, 2009
GSID announced that a Phase III clinical trial of an investigational HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection. The press release is available here (PDF).
September 9, 2009
GSID co-founder Dr. Phillip Berman has received a major grant from the NIH for his lab at UC Santa Cruz to follow up on the promising findings published in the August issue of Journal of Virology (see below). Press release available here.
August 1, 2009
Dr. Faruk Sinangil has co-authored a paper in the August issue of the Journal of Virology, which highlights a novel structural variant in an HIV coat protein that could be exploited in designing new vaccines. The research made use of the specimens and data in the GSID HIV Repository. Abstract available here.
July 15, 2009
Dr. Faruk Sinangil has co-authored a paper in the July issue of Retrovirology, which looks at ethnic differences in the adaption rate of HIV gp120 in North American volunteers from the VAX004 trials. The complete article is available here.
December 5, 2008
Speaking at the Third Annual CAVD meeting in Seattle, Dr. Faruk Sinangil provided an update on using the GSID HIV Data Browser and specimen repository to identify epitopes recognized by broadly neutralizing antibodies. Copies of his presentation are available here (3.9 MB PDF File).
March 15, 2008
The School of Public Health at UC Berkeley has honored Dr. Donald Francis as an International Hero at their 12th annual Public Health Heroes Award Ceremony. A copy of the press release can be found here (140k PDF file). Prior to the ceremony, Dr. Francis was interviewed by Emeritus Professor Dr. Warren Winkelstein, and the conversation is available here.
December 4, 2007
For the first time, Dr. Faruk Sinangil shared the GSID HIV Data Browser with the HIV research community, as part of the 2nd Annual CAVD meeting in Lausanne, Switzerland. A copy of his presentation is available here (868k PDF file).
December 11, 2006
Dr. Donald Francis is interviewed by the San Jose Mercury News about his history and the founding of GSID. Interview available here (20k PDF file).
October 17, 2006
Co-founder Dr. Phillip Berman has left GSID to become professor and chair of the Department of Biomolecular Engineering at UC Santa Cruz. Press release available here.
